| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | enzyme regulator activity | CCNJL PSAP HTRA2 PPP1R12A PPP1R12B ARHGAP26 SIPA1L3 WASHC1 GRB2 RAPGEF1 PSMD1 ITIH4 TAOK2 ARHGAP1 WASH3P DLC1 PIK3R6 RASGRP3 SBF2 ROCK1 AKAP13 WDR41 RIC1 PLCE1 | 3.76e-05 | 1418 | 138 | 24 | GO:0030234 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 1.42e-04 | 3 | 138 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP26 SIPA1L3 GRB2 RAPGEF1 ARHGAP1 DLC1 RASGRP3 SBF2 AKAP13 WDR41 RIC1 PLCE1 | 2.12e-04 | 507 | 138 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP26 SIPA1L3 GRB2 RAPGEF1 ARHGAP1 DLC1 RASGRP3 SBF2 AKAP13 WDR41 RIC1 PLCE1 | 2.12e-04 | 507 | 138 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.44e-04 | 18 | 138 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.77e-04 | 129 | 138 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.82e-04 | 4 | 138 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 4.68e-04 | 5 | 138 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | neuropilin binding | 4.68e-04 | 5 | 138 | 2 | GO:0038191 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.41e-04 | 151 | 138 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 6.98e-04 | 6 | 138 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 9.73e-04 | 7 | 138 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.14e-03 | 231 | 138 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 1.26e-03 | 31 | 138 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.26e-03 | 31 | 138 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 1.29e-03 | 8 | 138 | 2 | GO:0141039 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.51e-03 | 33 | 138 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 1.65e-03 | 34 | 138 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.78e-03 | 321 | 138 | 8 | GO:0031267 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | CACNA1C PRKD2 PSAP HTRA2 PPP1R12A CLEC7A RAPGEF1 CLDN4 ITGAM CLOCK TFAP4 RYR2 LRRC52 TAOK2 DLC1 PIK3R6 BTG1 EIF4G1 PXN ROBO1 ROCK1 WDR41 MERTK NOS3 RIC1 | 8.42e-06 | 1430 | 138 | 25 | GO:0044093 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | CACNA1C PSAP HTRA2 PPP1R12A CLEC7A RAPGEF1 CLDN4 ITGAM TFAP4 TAOK2 DLC1 PIK3R6 BTG1 PXN ROBO1 ROCK1 WDR41 MERTK NOS3 RIC1 | 1.68e-05 | 1028 | 138 | 20 | GO:0043085 |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1C PDE4B CTTNBP2 MYOM1 ARHGAP26 WASHC1 MYOM3 GRB2 PDLIM5 RYR2 TAOK2 WASH3P DLC1 ALMS1 PXN ROCK1 AKAP13 CACNA1G | 3.84e-05 | 912 | 138 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | CACNA1C PDE4B WASHC1 GRB2 RYR2 TAOK2 WASH3P DLC1 ALMS1 PXN ROCK1 AKAP13 | 3.95e-05 | 438 | 138 | 12 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | CACNA1C SH3TC2 MYOM1 HTRA2 PPP1R12A WASHC1 ANO1 ICE1 CEP192 ITGAM CLOCK PARD6B ARHGAP1 BMP6 WASH3P AP2M1 BRCA1 CELSR2 GCC2 EIF4G1 HADH | 5.57e-05 | 1212 | 138 | 21 | GO:0060341 |
| GeneOntologyBiologicalProcess | signal transduction in response to DNA damage | 6.14e-05 | 200 | 138 | 8 | GO:0042770 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 6.17e-05 | 12 | 138 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 6.17e-05 | 12 | 138 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | regulation of autophagy | PSAP HTRA2 WASHC1 RB1CC1 USP10 WASH3P PIK3C2A EIF4G1 ROCK1 WDR41 POLDIP2 | 8.09e-05 | 400 | 138 | 11 | GO:0010506 |
| GeneOntologyBiologicalProcess | epithelial cell development | PSAP PODXL NUP210L PPP1R12A SIPA1L3 RAPGEF1 CLOCK BMP6 ROCK1 | 8.46e-05 | 269 | 138 | 9 | GO:0002064 |
| GeneOntologyBiologicalProcess | positive regulation of transport | CACNA1C MYOM1 WASHC1 ANO1 CLEC7A RAPGEF1 ICE1 ITGAM RYR2 LRRC52 BMP6 WASH3P AP2M1 APPL2 ALMS1 BRCA1 SYNJ1 CACNA1G MERTK | 1.08e-04 | 1081 | 138 | 19 | GO:0051050 |
| GeneOntologyBiologicalProcess | epithelium development | PRKD2 FRAS1 PSAP PODXL NUP210L PPP1R12A SIPA1L3 GRB2 CDH23 RAPGEF1 CLDN4 CLOCK SCX RYR2 BMP6 DLC1 ALMS1 BTG1 PXN ROBO1 ROCK1 PRKDC STRCP1 | 1.11e-04 | 1469 | 138 | 23 | GO:0060429 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.26e-04 | 15 | 138 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | FNIP2 PODXL WASHC1 CLEC7A GRB2 RAPGEF1 ICE1 CEP192 PDLIM5 USP10 WASH3P DLC1 ALMS1 BRCA1 EIF4G1 PXN ROBO1 ROCK1 POLDIP2 PLCE1 | 1.28e-04 | 1189 | 138 | 20 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis | 1.33e-04 | 3 | 138 | 2 | GO:1905451 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | PSAP HTRA2 PPP1R12A CLEC7A RAPGEF1 CLDN4 TFAP4 DLC1 ROBO1 ROCK1 WDR41 RIC1 | 1.36e-04 | 499 | 138 | 12 | GO:0051345 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 2.06e-04 | 179 | 138 | 7 | GO:0031023 | |
| GeneOntologyBiologicalProcess | circulatory system development | CACNA1C PRKD2 RAPGEF1 RB1CC1 YJEFN3 SCX PDLIM5 RYR2 MFGE8 DLC1 PIK3R6 BRCA1 PTPRM PIK3C2A BTG1 PXN ROBO1 ROCK1 AKAP13 CACNA1G PRKDC NOS3 | 2.31e-04 | 1442 | 138 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | PDE4B PSAP HTRA2 ANO1 CLEC7A GRB2 RAPGEF1 YJEFN3 TFAP4 RYR3 ITPR3 BMP6 APPL2 BRCA1 PIK3C2A ZNF592 AFG3L2 PXN CD274 ROCK1 PRKDC NOS3 | 2.49e-04 | 1450 | 138 | 22 | GO:1901701 |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 2.63e-04 | 247 | 138 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | PSAP HTRA2 PPP1R12A CLEC7A RAPGEF1 CLDN4 TFAP4 ITIH4 ARHGAP1 DLC1 RASGRP3 ROBO1 ROCK1 WDR41 NOS3 RIC1 | 2.64e-04 | 878 | 138 | 16 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of execution phase of apoptosis | 3.07e-04 | 20 | 138 | 3 | GO:1900119 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1C PDE4B MYOM1 PPP1R12B PDLIM5 RYR2 RYR3 PIK3C2A ROCK1 AKAP13 CACNA1G NOS3 | 3.16e-04 | 547 | 138 | 12 | GO:0003012 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | PRKD2 FLT3LG PSAP MYOM1 PODXL MYOM3 GRB2 YJEFN3 SCX MFGE8 DLC1 PIK3R6 BRCA1 PTPRM PIK3C2A BTG1 PXN ROBO1 ROCK1 AKAP13 PRKDC NOS3 | 3.41e-04 | 1483 | 138 | 22 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of protein localization | CACNA1C SH3TC2 MYOM1 HTRA2 WASHC1 ANO1 ICE1 CEP192 ITGAM CLOCK BMP6 WASH3P AP2M1 BRCA1 CELSR2 GCC2 EIF4G1 HADH | 3.45e-04 | 1087 | 138 | 18 | GO:0032880 |
| GeneOntologyBiologicalProcess | dendritic cell antigen processing and presentation | 3.57e-04 | 21 | 138 | 3 | GO:0002468 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYOM1 WASHC1 MYOM3 CEP192 USP10 WASH3P ALMS1 BRCA1 AKAP13 PRKDC POLDIP2 | 3.59e-04 | 475 | 138 | 11 | GO:0140694 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SZT2 SIPA1L3 ANO1 CDH23 LAMB3 LAMC3 CLDN4 PDLIM5 TAOK2 PARD6B DLC1 CELSR2 PTPRM AFG3L2 PXN ROBO1 ROCK1 PRKDC STRCP1 | 3.84e-04 | 1194 | 138 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 4.05e-04 | 52 | 138 | 4 | GO:0010824 | |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | PSAP HTRA2 ARHGAP26 WASHC1 RB1CC1 USP10 WASH3P PIK3C2A SBF2 EIF4G1 ROCK1 WDR41 POLDIP2 | 4.30e-04 | 650 | 138 | 13 | GO:0061919 |
| GeneOntologyBiologicalProcess | autophagy | PSAP HTRA2 ARHGAP26 WASHC1 RB1CC1 USP10 WASH3P PIK3C2A SBF2 EIF4G1 ROCK1 WDR41 POLDIP2 | 4.30e-04 | 650 | 138 | 13 | GO:0006914 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 4.31e-04 | 266 | 138 | 8 | GO:0019722 | |
| GeneOntologyBiologicalProcess | regulation of Fc-gamma receptor signaling pathway involved in phagocytosis | 4.39e-04 | 5 | 138 | 2 | GO:1905449 | |
| GeneOntologyBiologicalProcess | cell junction assembly | PODXL RAPGEF1 CLDN4 PDLIM5 TAOK2 PARD6B DLC1 EIF4G1 PXN ROBO1 ROCK1 POLDIP2 | 4.50e-04 | 569 | 138 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | focal adhesion assembly | 4.91e-04 | 97 | 138 | 5 | GO:0048041 | |
| GeneOntologyBiologicalProcess | secretion | CACNA1C PSAP MYOM1 WASHC1 ANO1 ITGAM CLOCK BMP6 WASH3P CELSR2 SYNJ1 PIK3C2A CORIN CACNA1G WDR41 HADH MERTK RIC1 TANGO6 | 5.05e-04 | 1221 | 138 | 19 | GO:0046903 |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 5.35e-04 | 24 | 138 | 3 | GO:0048015 | |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 5.87e-04 | 213 | 138 | 7 | GO:0045807 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | CACNA1C SH3TC2 MYOM1 HTRA2 ANO1 ICE1 CEP192 ITGAM CLOCK BMP6 BRCA1 GCC2 HADH | 6.03e-04 | 674 | 138 | 13 | GO:0070201 |
| GeneOntologyBiologicalProcess | response to magnesium ion | 6.05e-04 | 25 | 138 | 3 | GO:0032026 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1C PDE4B CDH23 PKDREJ RYR2 RYR3 ITPR3 AFG3L2 CACNA1G NOS3 PLCE1 | 6.38e-04 | 509 | 138 | 11 | GO:0006816 |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol import | 6.55e-04 | 6 | 138 | 2 | GO:1904109 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 6.55e-04 | 6 | 138 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | regulation of centriole replication | 6.81e-04 | 26 | 138 | 3 | GO:0046599 | |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | 7.10e-04 | 359 | 138 | 9 | GO:0002429 | |
| GeneOntologyBiologicalProcess | secretion by cell | CACNA1C PSAP MYOM1 WASHC1 ANO1 ITGAM CLOCK BMP6 WASH3P SYNJ1 PIK3C2A CACNA1G WDR41 HADH MERTK RIC1 TANGO6 | 7.59e-04 | 1064 | 138 | 17 | GO:0032940 |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 8.00e-04 | 108 | 138 | 5 | GO:0007044 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | FNIP2 FLT3LG PPP1R12A CLEC7A RB1CC1 TAOK2 BMP6 DLC1 PIK3R6 EIF4G1 PXN ROBO1 ROCK1 MERTK NOS3 | 8.15e-04 | 879 | 138 | 15 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | FNIP2 FLT3LG PPP1R12A CLEC7A RB1CC1 TAOK2 BMP6 DLC1 PIK3R6 EIF4G1 PXN ROBO1 ROCK1 MERTK NOS3 | 8.15e-04 | 879 | 138 | 15 | GO:0045937 |
| GeneOntologyBiologicalProcess | cell junction organization | CTTNBP2 PODXL RAPGEF1 CLDN4 ITGAM PDLIM5 TAOK2 PARD6B BMP6 DLC1 AFG3L2 EIF4G1 PXN ROBO1 ROCK1 POLDIP2 | 8.16e-04 | 974 | 138 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | centrosome cycle | 8.35e-04 | 164 | 138 | 6 | GO:0007098 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 8.42e-04 | 63 | 138 | 4 | GO:0046605 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 8.42e-04 | 63 | 138 | 4 | GO:0003179 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 7.40e-06 | 107 | 139 | 7 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 7.40e-06 | 107 | 139 | 7 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 1.33e-05 | 117 | 139 | 7 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.41e-05 | 118 | 139 | 7 | GO:0032432 | |
| GeneOntologyCellularComponent | DNA repair complex | 1.50e-05 | 23 | 139 | 4 | GO:1990391 | |
| GeneOntologyCellularComponent | A band | 2.45e-05 | 52 | 139 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | sarcomere | CACNA1C PDE4B MYOM1 PPP1R12A PPP1R12B MYOM3 PDLIM5 RYR2 RYR3 | 4.46e-05 | 249 | 139 | 9 | GO:0030017 |
| GeneOntologyCellularComponent | Z disc | 6.87e-05 | 151 | 139 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | myofibril | CACNA1C PDE4B MYOM1 PPP1R12A PPP1R12B MYOM3 PDLIM5 RYR2 RYR3 | 9.05e-05 | 273 | 139 | 9 | GO:0030016 |
| GeneOntologyCellularComponent | I band | 1.24e-04 | 166 | 139 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.26e-04 | 73 | 139 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | cell leading edge | PODXL WASHC1 CTTNBP2NL ARHGAP1 WASH3P DLC1 APPL2 PTPRM PXN ROBO1 ROCK1 PLCE1 | 1.31e-04 | 500 | 139 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | contractile muscle fiber | CACNA1C PDE4B MYOM1 PPP1R12A PPP1R12B MYOM3 PDLIM5 RYR2 RYR3 | 1.43e-04 | 290 | 139 | 9 | GO:0043292 |
| GeneOntologyCellularComponent | centriole | 1.55e-04 | 172 | 139 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | lamellipodium | 1.56e-04 | 230 | 139 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | centrosome | FNIP2 CCNJL PDE4B PODXL PPP1R12A WASHC1 CDH23 CEP192 FIGN CEP128 WASH3P EYS ALMS1 BRCA1 SCLT1 | 1.92e-04 | 770 | 139 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | RNASEH2B KANSL1L POLR2B WASHC1 PSMD1 DARS1 CEP128 WASH3P BRCA1 RASGRP3 EIF4G1 PRKDC WDR41 TAF11 MED27 SCLT1 RIC1 | 2.54e-04 | 972 | 139 | 17 | GO:0140535 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1C PDE4B EVC2 HTRA2 TSNARE1 COX7A1 ANO1 GRB2 CDH23 CLDN4 YJEFN3 ITGAM RYR2 RYR3 LRRC52 AP2M1 PIK3R6 SYNJ1 PIK3C2A AFG3L2 CACNA1G SCLT1 | 3.61e-04 | 1498 | 139 | 22 | GO:0098796 |
| GeneOntologyCellularComponent | microtubule organizing center | FNIP2 CCNJL PDE4B PODXL PPP1R12A WASHC1 CDH23 CEP192 FIGN CEP128 WASH3P EYS ALMS1 BRCA1 ROCK1 SCLT1 | 4.10e-04 | 919 | 139 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 4.14e-04 | 335 | 139 | 9 | GO:0061695 | |
| GeneOntologyCellularComponent | actin cytoskeleton | CTTNBP2 PPP1R12A PPP1R12B SIPA1L3 CTTNBP2NL PDLIM5 TAOK2 DLC1 PXN CD274 CORIN AKAP13 | 4.75e-04 | 576 | 139 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | guanyl-nucleotide exchange factor complex | 5.26e-04 | 24 | 139 | 3 | GO:0032045 | |
| GeneOntologyCellularComponent | vesicle membrane | MGAM PSAP ARHGAP26 WASHC1 GRB2 MPEG1 RAPGEF1 ITGAM ITPR3 TAOK2 ARHGAP1 WASH3P MFGE8 AP2M1 APPL2 SYNJ1 SBF2 CD274 NOS3 | 1.25e-03 | 1325 | 139 | 19 | GO:0012506 |
| GeneOntologyCellularComponent | Atg1/ULK1 kinase complex | 1.53e-03 | 9 | 139 | 2 | GO:1990316 | |
| GeneOntologyCellularComponent | apical part of cell | MGAM PODXL SIPA1L3 ANO1 CDH23 CLDN4 ITPR3 PARD6B PTPRH ADGRG2 NOS3 | 2.04e-03 | 592 | 139 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 2.18e-03 | 269 | 139 | 7 | GO:0036464 | |
| GeneOntologyCellularComponent | pi-body | 2.32e-03 | 11 | 139 | 2 | GO:0071546 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1C PDE4B COX7A1 ANO1 CLDN4 YJEFN3 RYR2 RYR3 LRRC52 CACNA1G | 2.64e-03 | 523 | 139 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 3.13e-03 | 287 | 139 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | cell cortex | 3.43e-03 | 371 | 139 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.54e-03 | 46 | 139 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1C PDE4B COX7A1 ANO1 CLDN4 YJEFN3 RYR2 RYR3 LRRC52 CACNA1G | 3.78e-03 | 550 | 139 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 3.79e-03 | 14 | 139 | 2 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 3.79e-03 | 14 | 139 | 2 | GO:0060091 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.84e-03 | 378 | 139 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 4.02e-03 | 157 | 139 | 5 | GO:1902554 | |
| Domain | GPS | 4.31e-06 | 34 | 135 | 5 | SM00303 | |
| Domain | GPS | 6.63e-06 | 37 | 135 | 5 | IPR000203 | |
| Domain | RIH_assoc-dom | 7.27e-06 | 6 | 135 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.27e-06 | 6 | 135 | 3 | PF08709 | |
| Domain | RIH_assoc | 7.27e-06 | 6 | 135 | 3 | PF08454 | |
| Domain | RIH_dom | 7.27e-06 | 6 | 135 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.27e-06 | 6 | 135 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.27e-06 | 6 | 135 | 3 | IPR015925 | |
| Domain | - | 7.27e-06 | 6 | 135 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.27e-06 | 6 | 135 | 3 | PF01365 | |
| Domain | MIR | 4.27e-05 | 10 | 135 | 3 | PF02815 | |
| Domain | MIR_motif | 4.27e-05 | 10 | 135 | 3 | IPR016093 | |
| Domain | MIR | 4.27e-05 | 10 | 135 | 3 | PS50919 | |
| Domain | MIR | 4.27e-05 | 10 | 135 | 3 | SM00472 | |
| Domain | EGF_LAM_2 | 6.18e-05 | 30 | 135 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 6.18e-05 | 30 | 135 | 4 | PS01248 | |
| Domain | EGF_Lam | 1.15e-04 | 35 | 135 | 4 | SM00180 | |
| Domain | GPS | 1.15e-04 | 35 | 135 | 4 | PF01825 | |
| Domain | Laminin_EGF | 1.15e-04 | 35 | 135 | 4 | PF00053 | |
| Domain | GPS | 1.29e-04 | 36 | 135 | 4 | PS50221 | |
| Domain | PRKG1_interact | 1.55e-04 | 3 | 135 | 2 | IPR031775 | |
| Domain | Ryanodine_rcpt | 1.55e-04 | 3 | 135 | 2 | IPR003032 | |
| Domain | PRKG1_interact | 1.55e-04 | 3 | 135 | 2 | PF15898 | |
| Domain | MYPT1/MYPT2_chordates | 1.55e-04 | 3 | 135 | 2 | IPR017401 | |
| Domain | Ryanrecept_TM4-6 | 1.55e-04 | 3 | 135 | 2 | IPR009460 | |
| Domain | RyR | 1.55e-04 | 3 | 135 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.55e-04 | 3 | 135 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.55e-04 | 3 | 135 | 2 | IPR013333 | |
| Domain | Laminin_EGF | 1.59e-04 | 38 | 135 | 4 | IPR002049 | |
| Domain | Laminin_N | 1.93e-04 | 16 | 135 | 3 | IPR008211 | |
| Domain | LamNT | 1.93e-04 | 16 | 135 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 1.93e-04 | 16 | 135 | 3 | PS51117 | |
| Domain | Laminin_N | 1.93e-04 | 16 | 135 | 3 | PF00055 | |
| Domain | Cortactin-binding_p2_N | 3.08e-04 | 4 | 135 | 2 | IPR019131 | |
| Domain | CortBP2 | 3.08e-04 | 4 | 135 | 2 | PF09727 | |
| Domain | 7tm_2 | 4.65e-04 | 50 | 135 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.65e-04 | 50 | 135 | 4 | PS00650 | |
| Domain | Galactose-bd-like | 6.01e-04 | 94 | 135 | 5 | IPR008979 | |
| Domain | GPCR_2_secretin-like | 9.31e-04 | 60 | 135 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 9.31e-04 | 60 | 135 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 9.90e-04 | 61 | 135 | 4 | PS50261 | |
| Domain | fn3 | 1.16e-03 | 162 | 135 | 6 | PF00041 | |
| Domain | RASGEF_CAT | 1.18e-03 | 29 | 135 | 3 | PS50009 | |
| Domain | ZF_DAG_PE_1 | 1.19e-03 | 64 | 135 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.19e-03 | 64 | 135 | 4 | PS50081 | |
| Domain | C1 | 1.26e-03 | 65 | 135 | 4 | SM00109 | |
| Domain | RasGEF | 1.30e-03 | 30 | 135 | 3 | PF00617 | |
| Domain | - | 1.30e-03 | 30 | 135 | 3 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 1.30e-03 | 30 | 135 | 3 | IPR001895 | |
| Domain | RasGEF | 1.30e-03 | 30 | 135 | 3 | SM00147 | |
| Domain | Ras_GEF_dom | 1.30e-03 | 30 | 135 | 3 | IPR023578 | |
| Domain | PE/DAG-bd | 1.33e-03 | 66 | 135 | 4 | IPR002219 | |
| Domain | PH | 1.40e-03 | 229 | 135 | 7 | PF00169 | |
| Domain | Ion_trans_dom | 1.43e-03 | 114 | 135 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.43e-03 | 114 | 135 | 5 | PF00520 | |
| Domain | VDCCAlpha1 | 2.25e-03 | 10 | 135 | 2 | IPR002077 | |
| Domain | FN3 | 2.28e-03 | 185 | 135 | 6 | SM00060 | |
| Domain | EGF_1 | 2.56e-03 | 255 | 135 | 7 | PS00022 | |
| Domain | EGF-like_CS | 2.92e-03 | 261 | 135 | 7 | IPR013032 | |
| Domain | EGF_2 | 3.17e-03 | 265 | 135 | 7 | PS01186 | |
| Domain | FN3 | 3.27e-03 | 199 | 135 | 6 | PS50853 | |
| Domain | PH | 4.12e-03 | 278 | 135 | 7 | SM00233 | |
| Domain | FN3_dom | 4.16e-03 | 209 | 135 | 6 | IPR003961 | |
| Domain | PH_DOMAIN | 4.21e-03 | 279 | 135 | 7 | PS50003 | |
| Domain | PH_domain | 4.29e-03 | 280 | 135 | 7 | IPR001849 | |
| Domain | PI3/4_kinase_CS | 5.12e-03 | 15 | 135 | 2 | IPR018936 | |
| Domain | ConA-like_dom | 5.21e-03 | 219 | 135 | 6 | IPR013320 | |
| Domain | - | 5.82e-03 | 16 | 135 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.82e-03 | 16 | 135 | 2 | SM00146 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 6.90e-05 | 11 | 108 | 3 | M47958 | |
| Pathway | WP_FOCAL_ADHESION | 9.38e-05 | 187 | 108 | 8 | MM15913 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.12e-04 | 33 | 108 | 4 | MM1426 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.27e-04 | 34 | 108 | 4 | M3342 | |
| Pathway | WP_FOCAL_ADHESION | 1.44e-04 | 199 | 108 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.44e-04 | 199 | 108 | 8 | M7253 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.83e-04 | 69 | 108 | 5 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.96e-04 | 70 | 108 | 5 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.96e-04 | 70 | 108 | 5 | MM15597 | |
| Pathway | WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION | 2.19e-04 | 159 | 108 | 7 | M48090 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 2.41e-04 | 40 | 108 | 4 | M62 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.55e-04 | 74 | 108 | 5 | M41807 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.65e-04 | 41 | 108 | 4 | M27778 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 3.88e-04 | 19 | 108 | 3 | M27493 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.88e-04 | 19 | 108 | 3 | M47760 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 4.34e-04 | 178 | 108 | 7 | M2890 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRKD2 FRAS1 SZT2 ARHGAP26 TSNARE1 SIPA1L3 MYOM3 RAPGEF1 LAMB3 LAMC3 ICE1 CLDN4 CEP192 ITPR3 TAOK2 CELSR2 SYNJ1 ZNF592 FANCI SBF2 EIF4G1 OSBPL5 PXN AKAP13 PRKDC RIC1 | 4.96e-13 | 1105 | 142 | 26 | 35748872 |
| Pubmed | PRKD2 POLDIP3 PPP1R12A PPP1R12B KIF21A SIPA1L3 POLR2B GRB2 PSMD1 DARS1 PDLIM5 ITPR3 USP10 RCOR1 AP2M1 PIK3C2A NAT10 AFG3L2 EIF4G1 PXN PRKDC MED27 | 7.84e-09 | 1247 | 142 | 22 | 27684187 | |
| Pubmed | PMS1 PPP1R12B SIPA1L3 POLR2B GRB2 PSMD1 CEP192 RB1CC1 ITPR3 ARHGAP1 PTPRH PTPRM FDFT1 FANCI SBF2 NAT10 AFG3L2 PXN ROBO1 ROCK1 | 1.13e-08 | 1049 | 142 | 20 | 27880917 | |
| Pubmed | KANSL1L CTTNBP2 PSAP MYOM1 MYOM3 PSMD1 APPL2 ALMS1 PIK3C2A ZNF592 FDFT1 AFG3L2 PXN PLCE1 | 1.87e-08 | 497 | 142 | 14 | 23414517 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MYOM1 POLDIP3 SIPA1L3 CDH23 ICE1 LRRC52 ZNF592 GCC2 EIF4G1 AKAP13 PRKDC HADH | 3.39e-08 | 361 | 142 | 12 | 26167880 |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 29476115 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 20801872 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PRKD2 LAMB4 CTTNBP2 POLDIP3 GRB2 PSMD1 ICE1 CEP192 CTTNBP2NL TFAP4 USP10 BRCA1 PIK3C2A FANCI GCC2 AFG3L2 EIF4G1 SCLT1 | 1.64e-07 | 1005 | 142 | 18 | 19615732 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.76e-07 | 38 | 142 | 5 | 30786075 | |
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 6.08e-07 | 17 | 142 | 4 | 27725084 | |
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 6.62e-07 | 5 | 142 | 3 | 11701968 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C PPP1R12A TSNARE1 SIPA1L3 PSMD1 CEP192 YJEFN3 NAALADL2 TFAP4 USP10 GTF3C1 GCC2 SBF2 NAT10 TOX3 OSBPL5 AKAP13 QSER1 MED27 ADGRD1 RIC1 | 7.34e-07 | 1489 | 142 | 21 | 28611215 |
| Pubmed | PSMD1 ICE1 RB1CC1 RCOR1 GTF3C1 ALMS1 SYNJ1 ZNF592 GCC2 PXN TANGO6 | 1.29e-06 | 418 | 142 | 11 | 34709266 | |
| Pubmed | PRKD2 PSAP KIF21A SIPA1L3 PSMD1 DARS1 PDLIM5 RYR3 ARHGAP1 MFGE8 AP2M1 APPL2 SYNJ1 ZNF592 EIF4G1 ROBO1 PRKDC POLDIP2 MERTK | 1.31e-06 | 1285 | 142 | 19 | 35914814 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.32e-06 | 6 | 142 | 3 | 25966694 | |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 1.32e-06 | 6 | 142 | 3 | 18159949 | |
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 20519450 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 23463619 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 16352659 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.32e-06 | 6 | 142 | 3 | 16844763 | |
| Pubmed | SZT2 ARHGAP26 KIF21A ICE1 CLOCK CTTNBP2NL TAOK2 USP10 ZNF592 NAT10 OSBPL5 CACNA1G | 1.97e-06 | 529 | 142 | 12 | 14621295 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 11860456 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PRKD2 POLDIP3 ARHGAP26 GRB2 PSMD1 ITPR3 ARHGAP1 RCOR1 AP2M1 GTF3C1 PTPRH PTPRM FANCI AFG3L2 PXN PRKDC | 2.56e-06 | 974 | 142 | 16 | 28675297 |
| Pubmed | RNASEH2B MED16 PPP1R12A POLR2B PDLIM5 RCOR1 ALMS1 BRCA1 ZNF592 AFG3L2 ROCK1 POLDIP2 MED27 | 2.66e-06 | 645 | 142 | 13 | 25281560 | |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 3.68e-06 | 8 | 142 | 3 | 10655549 | |
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 11784029 | ||
| Pubmed | Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. | 3.68e-06 | 8 | 142 | 3 | 18097035 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.68e-06 | 8 | 142 | 3 | 19033399 | |
| Pubmed | 4.07e-06 | 102 | 142 | 6 | 11214970 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 9.94e-06 | 33 | 142 | 4 | 25713288 | |
| Pubmed | PDE4B CTTNBP2 PPP1R12A KIF21A SIPA1L3 ITIH4 TAOK2 USP10 RCOR1 CELSR2 SYNJ1 NAT10 EIF4G1 ROCK1 QSER1 | 1.01e-05 | 963 | 142 | 15 | 28671696 | |
| Pubmed | Streamlined analysis schema for high-throughput identification of endogenous protein complexes. | 1.11e-05 | 71 | 142 | 5 | 20133760 | |
| Pubmed | Human mediator subunit MED26 functions as a docking site for transcription elongation factors. | 1.27e-05 | 73 | 142 | 5 | 21729782 | |
| Pubmed | 1.43e-05 | 12 | 142 | 3 | 19095005 | ||
| Pubmed | Kinases, myosin phosphatase and Rho proteins: curiouser and curiouser. | 1.66e-05 | 2 | 142 | 2 | 10200412 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19920353 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 35036076 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 8898078 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24026422 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 18586264 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 14550562 | ||
| Pubmed | TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness. | 1.66e-05 | 2 | 142 | 2 | 23447579 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 20360401 | ||
| Pubmed | BRCA1 modulates the autophosphorylation status of DNA-PKcs in S phase of the cell cycle. | 1.66e-05 | 2 | 142 | 2 | 25223785 | |
| Pubmed | Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression. | 1.66e-05 | 2 | 142 | 2 | 33299141 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.66e-05 | 2 | 142 | 2 | 21531043 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16678258 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 38786015 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11576544 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24285081 | ||
| Pubmed | Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. | 1.66e-05 | 2 | 142 | 2 | 10087910 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 7982917 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19797068 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 29860109 | ||
| Pubmed | Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans. | 1.66e-05 | 2 | 142 | 2 | 19451235 | |
| Pubmed | The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer. | 1.66e-05 | 2 | 142 | 2 | 30045136 | |
| Pubmed | WASH and the Arp2/3 complex regulate endosome shape and trafficking. | 1.66e-05 | 2 | 142 | 2 | 20175130 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 8690467 | ||
| Pubmed | Inflammatory bone loss associated with MFG-E8 deficiency is rescued by teriparatide. | 1.66e-05 | 2 | 142 | 2 | 29475373 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25448629 | ||
| Pubmed | Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC. | 1.66e-05 | 2 | 142 | 2 | 27003362 | |
| Pubmed | Genomic structure, alternative splice forms and normal and mutant alleles of cadherin 23 (Cdh23). | 1.66e-05 | 2 | 142 | 2 | 11750125 | |
| Pubmed | The molecular basis of the genesis of basal tone in internal anal sphincter. | 1.66e-05 | 2 | 142 | 2 | 27101932 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9388224 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 38254202 | ||
| Pubmed | Phagocytosis executes delayed neuronal death after focal brain ischemia. | 1.66e-05 | 2 | 142 | 2 | 24101459 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25889536 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9891051 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23417432 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19811837 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 39390016 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 14985349 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 15879090 | ||
| Pubmed | PPP1R12A POLR2B PDLIM5 USP10 GTF3C1 ALMS1 SYNJ1 NAT10 PRKDC QSER1 MED27 | 1.70e-05 | 549 | 142 | 11 | 38280479 | |
| Pubmed | MED16 POLDIP3 POLR2B TFAP4 USP10 RCOR1 AP2M1 GTF3C1 ZNF592 FANCI NAT10 EIF4G1 PRKDC QSER1 MED27 | 1.84e-05 | 1014 | 142 | 15 | 32416067 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.81e-05 | 212 | 142 | 7 | 33853758 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 2.98e-05 | 87 | 142 | 5 | 17148452 | |
| Pubmed | POLDIP3 POLR2B LAMB3 DARS1 USP10 GTF3C1 SBF2 NAT10 AFG3L2 AKAP13 PRKDC | 3.88e-05 | 601 | 142 | 11 | 33658012 | |
| Pubmed | MED16 PPP1R12A PPP1R12B SIPA1L3 POLR2B ICE1 CTTNBP2NL TAOK2 PARD6B USP10 APPL2 BRCA1 PIK3C2A ZNF592 AFG3L2 EIF4G1 PXN MED27 | 4.11e-05 | 1497 | 142 | 18 | 31527615 | |
| Pubmed | Complement Targets Newborn Retinal Ganglion Cells for Phagocytic Elimination by Microglia. | 4.35e-05 | 17 | 142 | 3 | 30647151 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RC3H2 PPP1R12A DARS1 PDLIM5 ARHGAP1 USP10 BRCA1 PIK3C2A NAT10 EIF4G1 PXN AKAP13 | 4.48e-05 | 724 | 142 | 12 | 36232890 |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 9428629 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 18403125 | ||
| Pubmed | Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. | 4.95e-05 | 3 | 142 | 2 | 11283607 | |
| Pubmed | An NGS-based genotyping in LQTS; minor genes are no longer minor. | 4.95e-05 | 3 | 142 | 2 | 32681117 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 18077344 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 31913757 | ||
| Pubmed | BRCA1-Dependent Translational Regulation in Breast Cancer Cells. | 4.95e-05 | 3 | 142 | 2 | 23805307 | |
| Pubmed | Mesenteric lymph node CD11b- CD103+ PD-L1High dendritic cells highly induce regulatory T cells. | 4.95e-05 | 3 | 142 | 2 | 28423181 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 26881253 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 25205036 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21531981 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 12163569 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 7512734 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 10567269 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 38086439 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 18434746 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 22155728 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 4.95e-05 | 3 | 142 | 2 | 9204703 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21881589 | ||
| Interaction | TOP3B interactions | PRKD2 RC3H2 FRAS1 SZT2 POLDIP3 ARHGAP26 TSNARE1 SIPA1L3 MYOM3 RAPGEF1 LAMB3 DARS1 LAMC3 ICE1 CLDN4 CEP192 ITPR3 TAOK2 USP10 CELSR2 SYNJ1 ZNF592 FANCI SBF2 EIF4G1 OSBPL5 PXN AKAP13 PRKDC RIC1 | 4.27e-08 | 1470 | 137 | 30 | int:TOP3B |
| Interaction | ANKFY1 interactions | RC3H2 PPP1R12B ARHGAP1 RCOR1 APPL2 ALMS1 SYNJ1 PIK3C2A GCC2 CD274 ROCK1 | 6.52e-07 | 236 | 137 | 11 | int:ANKFY1 |
| Interaction | AP2B1 interactions | RC3H2 SIPA1L3 GRB2 PSMD1 CEP192 CEP128 AP2M1 ALMS1 BRCA1 SYNJ1 PIK3C2A GCC2 PXN | 1.64e-06 | 373 | 137 | 13 | int:AP2B1 |
| Interaction | TNRC6B interactions | RNASEH2B RC3H2 CEP192 RB1CC1 CEP128 RCOR1 AP2M1 ALMS1 BRCA1 PXN SCLT1 | 3.69e-06 | 282 | 137 | 11 | int:TNRC6B |
| Interaction | PHF21A interactions | PSMD1 ICE1 RB1CC1 CLOCK RCOR1 ALMS1 SYNJ1 ZNF592 GCC2 PXN SCLT1 TANGO6 | 4.04e-06 | 343 | 137 | 12 | int:PHF21A |
| Interaction | KRT18 interactions | PDE4B SIPA1L3 GRB2 PSMD1 DARS1 CEP192 RB1CC1 CEP128 ITPR3 ALMS1 BRCA1 TEKT4 TANGO6 | 5.84e-06 | 419 | 137 | 13 | int:KRT18 |
| Interaction | MED28 interactions | 1.45e-05 | 116 | 137 | 7 | int:MED28 | |
| Interaction | ANKRD28 interactions | MYOM1 PPP1R12B CEP192 CEP128 CTTNBP2NL USP10 AP2M1 BRCA1 PRKDC | 3.36e-05 | 235 | 137 | 9 | int:ANKRD28 |
| Interaction | DNAJC7 interactions | EVC2 MED16 POLR2B CEP128 ITPR3 ARHGAP1 PIK3C2A AFG3L2 PRKDC WDR41 SCLT1 TANGO6 | 3.43e-05 | 425 | 137 | 12 | int:DNAJC7 |
| Cytoband | 8q11 | 1.41e-04 | 6 | 142 | 2 | 8q11 | |
| GeneFamily | Laminin subunits | 3.28e-05 | 12 | 98 | 3 | 626 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 8.22e-05 | 16 | 98 | 3 | 14 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 8.69e-05 | 3 | 98 | 2 | 287 | |
| GeneFamily | Fibronectin type III domain containing | 2.35e-04 | 160 | 98 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.43e-04 | 161 | 98 | 6 | 593 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.55e-04 | 181 | 98 | 6 | 694 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 6.00e-04 | 7 | 98 | 2 | 917 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 7.97e-04 | 8 | 98 | 2 | 658 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.97e-04 | 206 | 98 | 6 | 682 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.52e-03 | 50 | 98 | 3 | 721 | |
| GeneFamily | Parkinson disease associated genes | 3.32e-03 | 16 | 98 | 2 | 672 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.19e-03 | 20 | 98 | 2 | 548 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 5.19e-03 | 20 | 98 | 2 | 1371 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.71e-03 | 21 | 98 | 2 | 813 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 8.04e-03 | 25 | 98 | 2 | 504 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.68e-03 | 26 | 98 | 2 | 253 | |
| GeneFamily | PDZ domain containing | 9.42e-03 | 152 | 98 | 4 | 1220 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.09e-05 | 196 | 140 | 8 | M3008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 PODXL PPP1R12A POLR2B RB1CC1 CLOCK PDLIM5 RCOR1 DLC1 BRCA1 PTPRM PIK3C2A GCC2 ROCK1 AKAP13 PLCE1 | 1.43e-05 | 856 | 140 | 16 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.81e-05 | 152 | 140 | 7 | M39243 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 2.05e-05 | 155 | 140 | 7 | M39246 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | KANSL1L PODXL ARHGAP26 KIF21A POLR2B CEP192 RB1CC1 FIGN CEP128 CTTNBP2NL IGSF10 ALMS1 FDFT1 GCC2 NAT10 TOX3 CD274 ROCK1 CACNA1G QSER1 SCLT1 RIC1 | 1.89e-05 | 1252 | 138 | 22 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.07e-05 | 259 | 138 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3 | HTRA2 GPR33 CLEC7A MPEG1 PGAP6 CTTNBP2NL FDFT1 RASGRP3 SBF2 CD274 RIC1 | 9.26e-05 | 418 | 138 | 11 | GSM605836_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.00e-04 | 164 | 138 | 7 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k2_1000 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000_k-means-cluster#5 | CACNA1C MYOM1 MYOM3 COX7A1 CLEC7A MPEG1 SCX RYR2 IGSF10 CORIN ADGRD1 | 1.05e-04 | 424 | 138 | 11 | geo_heart_1000_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_1000 | PDE4B HTRA2 PODXL PGAP6 PDLIM5 ITPR3 PARD6B DLC1 PIK3R6 PIK3C2A RASGRP3 OSBPL5 CORIN MERTK MED27 NOS3 | 1.11e-04 | 837 | 138 | 16 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | PRKD2 SH3TC2 PDE4B PODXL ARHGAP26 CLEC7A MPEG1 CTTNBP2NL DLC1 PIK3R6 PTPRM RASGRP3 PXN NOS3 TANGO6 | 1.37e-04 | 764 | 138 | 15 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.44e-04 | 297 | 138 | 9 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k1 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.72e-04 | 179 | 138 | 7 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SH3TC2 PSAP ARHGAP26 KIF21A COX7A1 CDH23 SCX PARD6B RCOR1 APPL2 GTF3C1 BRCA1 GCC2 ROBO1 HADH PLCE1 | 1.96e-04 | 880 | 138 | 16 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | CCNJL SH3TC2 PSAP SZT2 KIF21A COX7A1 CDH23 SCX PARD6B RCOR1 BRCA1 GCC2 ROBO1 HADH MERTK PLCE1 | 2.06e-04 | 884 | 138 | 16 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_500 | PRKD2 PODXL ARHGAP26 CLEC7A MPEG1 CTTNBP2NL PIK3R6 PTPRM RASGRP3 NOS3 | 2.11e-04 | 384 | 138 | 10 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_500 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 2.20e-04 | 84 | 138 | 5 | GSM605862_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.23e-04 | 315 | 138 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_100 | 2.41e-04 | 19 | 138 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_100_k2 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-2 | HTRA2 GPR33 CLEC7A MPEG1 PGAP6 CTTNBP2NL RASGRP3 SBF2 CD274 RIC1 | 3.11e-04 | 403 | 138 | 10 | GSM605834_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | CACNA1C CEP192 CTTNBP2NL IGSF10 GCC2 ROCK1 CACNA1G QSER1 MERTK | 3.21e-04 | 331 | 138 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | FNIP2 PSAP GPR33 CLEC7A MPEG1 CTTNBP2NL ALMS1 RASGRP3 MERTK PLCE1 | 3.49e-04 | 409 | 138 | 10 | GSM538234_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | CACNA1C KANSL1L ARHGAP26 CEP192 CTTNBP2NL IGSF10 BMP6 FDFT1 GCC2 OSBPL5 ROCK1 AKAP13 CACNA1G QSER1 MERTK | 3.51e-04 | 834 | 138 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-1 | MYOM1 HTRA2 CLEC7A MPEG1 PGAP6 CTTNBP2NL RASGRP3 SBF2 CD274 RIC1 | 3.84e-04 | 414 | 138 | 10 | GSM538262_500 |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4 | 3.91e-04 | 53 | 138 | 4 | GSM854276_100 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#2_top-relative-expression-ranked_500 | 4.30e-04 | 97 | 138 | 5 | gudmap_developingKidney_e13.5_podocyte cells_500_k2 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.09e-08 | 190 | 142 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.14e-08 | 191 | 142 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.19e-08 | 192 | 142 | 9 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-08 | 194 | 142 | 9 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | CACNA1C FRAS1 MYOM1 PPP1R12B KIF21A MYOM3 PDLIM5 RYR2 RASGRP3 | 1.30e-08 | 194 | 142 | 9 | c3535f7cc0076653c72db582047cff053c322397 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-08 | 194 | 142 | 9 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.30e-08 | 194 | 142 | 9 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-08 | 196 | 142 | 9 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 1.42e-08 | 196 | 142 | 9 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-08 | 196 | 142 | 9 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 1.56e-08 | 198 | 142 | 9 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.30e-07 | 182 | 142 | 8 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.41e-07 | 184 | 142 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.73e-07 | 189 | 142 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.81e-07 | 190 | 142 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.88e-07 | 191 | 142 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.88e-07 | 191 | 142 | 8 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.04e-07 | 193 | 142 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 2.12e-07 | 194 | 142 | 8 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 2.20e-07 | 195 | 142 | 8 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.20e-07 | 195 | 142 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-07 | 195 | 142 | 8 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 2.20e-07 | 195 | 142 | 8 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-07 | 196 | 142 | 8 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 2.29e-07 | 196 | 142 | 8 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-07 | 198 | 142 | 8 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.47e-07 | 198 | 142 | 8 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.67e-07 | 200 | 142 | 8 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 2.67e-07 | 200 | 142 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.20e-07 | 153 | 142 | 7 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 166 | 142 | 7 | 91eeb48680dd07ae4115afacdc0a8f6fa18885e5 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 170 | 142 | 7 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.26e-06 | 170 | 142 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 174 | 142 | 7 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 174 | 142 | 7 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 175 | 142 | 7 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 176 | 142 | 7 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-06 | 178 | 142 | 7 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 183 | 142 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 184 | 142 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 184 | 142 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 184 | 142 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.21e-06 | 185 | 142 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 2.29e-06 | 186 | 142 | 7 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 187 | 142 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 187 | 142 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 187 | 142 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.46e-06 | 188 | 142 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-06 | 188 | 142 | 7 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.46e-06 | 188 | 142 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.55e-06 | 189 | 142 | 7 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.55e-06 | 189 | 142 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-06 | 189 | 142 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.55e-06 | 189 | 142 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-06 | 189 | 142 | 7 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-06 | 189 | 142 | 7 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|World / Lineage and Cell class | 2.64e-06 | 190 | 142 | 7 | 5aa62a363a25f4a110136263b21289a11e8c1e6d | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.64e-06 | 190 | 142 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.66e-06 | 122 | 142 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 192 | 142 | 7 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 192 | 142 | 7 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 192 | 142 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.82e-06 | 192 | 142 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 192 | 142 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-06 | 193 | 142 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 193 | 142 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 2.92e-06 | 193 | 142 | 7 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.02e-06 | 194 | 142 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 194 | 142 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 3.13e-06 | 195 | 142 | 7 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-06 | 196 | 142 | 7 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 3.24e-06 | 196 | 142 | 7 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-06 | 196 | 142 | 7 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-06 | 196 | 142 | 7 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.24e-06 | 196 | 142 | 7 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.24e-06 | 196 | 142 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-06 | 196 | 142 | 7 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.35e-06 | 197 | 142 | 7 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.35e-06 | 197 | 142 | 7 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-06 | 197 | 142 | 7 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.35e-06 | 197 | 142 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-06 | 197 | 142 | 7 | 8dd10962b6ba587512b2e68c762ade68c751cbc8 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.35e-06 | 197 | 142 | 7 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.35e-06 | 197 | 142 | 7 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.35e-06 | 197 | 142 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.46e-06 | 198 | 142 | 7 | 0f1feed8a37293ae02465909f99548ab58dc7ce5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-06 | 198 | 142 | 7 | acb84681569651447d684aa3960f0510d7ff17e8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.58e-06 | 199 | 142 | 7 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-06 | 199 | 142 | 7 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.58e-06 | 199 | 142 | 7 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.58e-06 | 199 | 142 | 7 | 7cbd98dd10c91584dee04593910031e90c1340b8 | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 3.58e-06 | 199 | 142 | 7 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-06 | 199 | 142 | 7 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.70e-06 | 200 | 142 | 7 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.70e-06 | 200 | 142 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.70e-06 | 200 | 142 | 7 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| Drug | U46619 | CACNA1C PRKD2 PPP1R12A PPP1R12B RYR2 RYR3 ITPR3 PTPRM ROCK1 CACNA1G NOS3 PLCE1 | 2.06e-07 | 285 | 140 | 12 | CID000005618 |
| Drug | NSC-711994 | 2.28e-07 | 3 | 140 | 3 | CID005471614 | |
| Drug | Fura-2AM | 5.73e-07 | 79 | 140 | 7 | CID000105091 | |
| Drug | CNS 1145 | 1.69e-06 | 33 | 140 | 5 | CID000190902 | |
| Drug | IHC-64 | 1.69e-06 | 33 | 140 | 5 | CID000162753 | |
| Drug | isradipine | 2.84e-06 | 100 | 140 | 7 | CID000003784 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | CACNA1C PRKD2 PPP1R12A PPP1R12B RYR2 RYR3 ITPR3 PIK3C2A ROCK1 CACNA1G NOS3 | 3.35e-06 | 308 | 140 | 11 | CID000001915 |
| Drug | gallopamil | 3.56e-06 | 67 | 140 | 6 | CID000001234 | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A | KANSL1L MED16 ARHGAP26 LAMC3 TFAP4 PDLIM5 PTPRM CACNA1G QSER1 | 3.58e-06 | 196 | 140 | 9 | 6832_UP |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.89e-06 | 198 | 140 | 9 | 6297_UP | |
| Drug | mercury | CACNA1C MGAM EVC2 MED16 PPP1R12A CDH23 RYR2 RYR3 ITPR3 PIK3C2A AFG3L2 CACNA1G MERTK NOS3 | 6.64e-06 | 542 | 140 | 14 | CID000023931 |
| Drug | escina | 7.33e-06 | 44 | 140 | 5 | CID006433489 | |
| Drug | manganese | CACNA1C MGAM LAMB4 PDE4B PPP1R12A POLR2B DARS1 LAMC3 ITGAM RYR2 RYR3 ITPR3 BRCA1 FDFT1 LPO CACNA1G NOS3 | 7.57e-06 | 791 | 140 | 17 | CID000023930 |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 7.82e-06 | 7 | 140 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 7.82e-06 | 7 | 140 | 3 | CID003081001 | |
| Drug | ts M | 1.13e-05 | 48 | 140 | 5 | CID000428025 | |
| Drug | papaverine | 1.36e-05 | 176 | 140 | 8 | CID000004680 | |
| Drug | Ro-26-9228 | 1.84e-05 | 26 | 140 | 4 | CID009889588 | |
| Drug | lanthanum | 2.16e-05 | 136 | 140 | 7 | CID000023926 | |
| Drug | Go6976 | 2.37e-05 | 190 | 140 | 8 | CID000003501 | |
| Drug | Cinildipine | 2.43e-05 | 56 | 140 | 5 | CID000002752 | |
| Drug | CAAC | 2.89e-05 | 29 | 140 | 4 | CID006436397 | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.96e-05 | 196 | 140 | 8 | 2270_UP | |
| Drug | Dantrolene-13C3 | 3.26e-05 | 145 | 140 | 7 | CID000002951 | |
| Drug | nilvadipine | 3.41e-05 | 60 | 140 | 5 | CID000004494 | |
| Drug | R 478 | 3.62e-05 | 11 | 140 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 3.62e-05 | 11 | 140 | 3 | CID003081323 | |
| Drug | IAA-94 | 3.69e-05 | 61 | 140 | 5 | CID000003667 | |
| Drug | Bay K 8644 | 4.05e-05 | 150 | 140 | 7 | CID000002303 | |
| Drug | lercanidipine | 4.32e-05 | 63 | 140 | 5 | CID000065866 | |
| Drug | loperamide | 4.74e-05 | 105 | 140 | 6 | CID000003954 | |
| Drug | fura 2 | 5.02e-05 | 65 | 140 | 5 | CID000057054 | |
| Drug | genistein | CACNA1C PRKD2 LAMB4 POLDIP3 GRB2 LAMC3 ITGAM RYR2 RYR3 ITPR3 BRCA1 PTPRM PIK3C2A BTG1 CD274 ROCK1 CACNA1G NOS3 PLCE1 | 5.56e-05 | 1117 | 140 | 19 | CID005280961 |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | CACNA1C PRKD2 PDE4B PPP1R12A PPP1R12B POLR2B RYR2 RYR3 ITPR3 RCOR1 CORIN CACNA1G NOS3 | 5.91e-05 | 577 | 140 | 13 | CID000000295 |
| Drug | lysosphingomyelin | 6.10e-05 | 160 | 140 | 7 | CID000005263 | |
| Drug | AC1L2AC7 | 6.70e-05 | 69 | 140 | 5 | CID000068733 | |
| Drug | mag-fura-2 | 7.73e-05 | 37 | 140 | 4 | CID000123839 | |
| Drug | BMPDA | 7.88e-05 | 14 | 140 | 3 | CID000119352 | |
| Drug | felodipine | 8.60e-05 | 169 | 140 | 7 | CID000003333 | |
| Drug | AC1NBU2S | 8.67e-05 | 117 | 140 | 6 | CID004473765 | |
| Drug | CAS 298-57-7 | 8.79e-05 | 73 | 140 | 5 | CID000002761 | |
| Drug | lavendustin A | 9.26e-05 | 171 | 140 | 7 | CID000003894 | |
| Drug | ethosuximide | 9.38e-05 | 74 | 140 | 5 | CID000003291 | |
| Drug | gpgG | 9.81e-05 | 15 | 140 | 3 | CID000485273 | |
| Drug | FPL 64176 | 9.81e-05 | 15 | 140 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 9.81e-05 | 15 | 140 | 3 | CID000125015 | |
| Drug | TMB-8 | 1.11e-04 | 176 | 140 | 7 | CID000005494 | |
| Drug | cis-diammineplatinum(II | 1.12e-04 | 3 | 140 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.12e-04 | 3 | 140 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 1.12e-04 | 3 | 140 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.12e-04 | 3 | 140 | 2 | CID009570289 | |
| Drug | dcaB | 1.12e-04 | 3 | 140 | 2 | CID000015340 | |
| Drug | 2-hydroxycarbazole | 1.12e-04 | 3 | 140 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.12e-04 | 3 | 140 | 2 | CID005748312 | |
| Drug | Clorocruoro Hem | 1.14e-04 | 123 | 140 | 6 | CID003518809 | |
| Drug | hydroxyoctanoate | 1.16e-04 | 41 | 140 | 4 | CID000094180 | |
| Drug | nisoldipine | 1.20e-04 | 78 | 140 | 5 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.28e-04 | 79 | 140 | 5 | CID005287890 | |
| Drug | halothane | 1.45e-04 | 314 | 140 | 9 | CID000003562 | |
| Drug | PC-PI | 1.74e-04 | 18 | 140 | 3 | CID000007693 | |
| Drug | magnesium | PRKD2 MGAM LAMB4 PDE4B POLR2B COX7A1 DARS1 LAMC3 ITGAM TFAP4 RYR2 RYR3 TAOK2 ARHGAP1 PIK3C2A FDFT1 GCC2 ROCK1 MERTK NOS3 | 1.78e-04 | 1325 | 140 | 20 | CID000000888 |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.84e-04 | 191 | 140 | 7 | 4451_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.96e-04 | 193 | 140 | 7 | 3624_DN | |
| Drug | europium | 2.02e-04 | 87 | 140 | 5 | CID000023981 | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.02e-04 | 194 | 140 | 7 | 5056_UP | |
| Drug | AC1MW7VF | 2.05e-04 | 19 | 140 | 3 | CID000414699 | |
| Drug | AC1L380G | 2.05e-04 | 19 | 140 | 3 | CID000084698 | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A | 2.09e-04 | 195 | 140 | 7 | 1946_UP | |
| Drug | Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.15e-04 | 196 | 140 | 7 | 3171_UP | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | 2.15e-04 | 196 | 140 | 7 | 4238_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 3039_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 5785_DN | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; PC3; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 7502_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 3056_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 3357_UP | |
| Drug | Praziquantel [55268-74-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.22e-04 | 197 | 140 | 7 | 3189_UP | |
| Drug | geranylgeranyl pyrophosphate | 2.23e-04 | 139 | 140 | 6 | CID000000735 | |
| Drug | PCB74 | 2.23e-04 | 4 | 140 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 2.23e-04 | 4 | 140 | 2 | CID006444275 | |
| Drug | magnaphoscal | 2.23e-04 | 4 | 140 | 2 | CID000168400 | |
| Drug | SC 38249 | 2.23e-04 | 4 | 140 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 2.23e-04 | 4 | 140 | 2 | CID000035682 | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; HL60; HT_HG-U133A | 2.29e-04 | 198 | 140 | 7 | 2333_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; HL60; HT_HG-U133A | 2.29e-04 | 198 | 140 | 7 | 2708_UP | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A | 2.29e-04 | 198 | 140 | 7 | 4759_DN | |
| Drug | AC1L1KS5 | 2.30e-04 | 334 | 140 | 9 | CID000005631 | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 2.36e-04 | 199 | 140 | 7 | 5048_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A | 2.36e-04 | 199 | 140 | 7 | 3073_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 140 | 7 | 6773_UP | |
| Drug | 3'-dCTP | 2.36e-04 | 90 | 140 | 5 | CID000153054 | |
| Drug | zaprinast | 2.41e-04 | 141 | 140 | 6 | CID000005722 | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A | 2.44e-04 | 200 | 140 | 7 | 3078_DN | |
| Drug | KW-3049 | 2.53e-04 | 50 | 140 | 4 | CID000002324 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.04e-05 | 12 | 136 | 3 | EFO_0801493 | |
| Disease | granulins measurement | 2.04e-05 | 12 | 136 | 3 | EFO_0008141 | |
| Disease | neuroimaging measurement | CTTNBP2 SZT2 PODXL SKIDA1 PSMD1 SLC25A26 TFAP4 TAOK2 BMP6 BRCA1 SYNJ1 RASGRP3 TOX3 ROBO1 QSER1 PLCE1 | 3.51e-05 | 1069 | 136 | 16 | EFO_0004346 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 6.31e-05 | 3 | 136 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 6.31e-05 | 3 | 136 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Atypical juvenile parkinsonism | 6.31e-05 | 3 | 136 | 2 | C4510873 | |
| Disease | coronary artery disease | PRKD2 PSAP PPP1R12B ARHGAP26 FIGN XKR4 CLOCK PDLIM5 ITIH4 IGSF10 DLC1 CELSR2 AKAP13 MERTK NOS3 PLCE1 | 1.28e-04 | 1194 | 136 | 16 | EFO_0001645 |
| Disease | FEV/FEC ratio | MGAM FRAS1 CTTNBP2 ARHGAP26 SKIDA1 ANO1 CDH23 CTTNBP2NL TFAP4 C5orf47 DLC1 PTPRM SBSPON RASGRP3 SBF2 WDR41 | 1.76e-04 | 1228 | 136 | 16 | EFO_0004713 |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 2.09e-04 | 5 | 136 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | diastolic blood pressure, systolic blood pressure | CACNA1C ANO1 PSMD1 FIGN PDLIM5 RYR2 MFGE8 DLC1 ALMS1 WDR41 TANGO6 | 2.86e-04 | 670 | 136 | 11 | EFO_0006335, EFO_0006336 |
| Disease | bipolar disorder, anorexia nervosa | 3.13e-04 | 6 | 136 | 2 | MONDO_0004985, MONDO_0005351 | |
| Disease | Bipolar Disorder | 3.83e-04 | 477 | 136 | 9 | C0005586 | |
| Disease | gestational age | 4.59e-04 | 138 | 136 | 5 | EFO_0005112 | |
| Disease | hyperuricemia | 4.72e-04 | 33 | 136 | 3 | EFO_0009104 | |
| Disease | retinal degeneration (implicated_via_orthology) | 4.72e-04 | 33 | 136 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | FNIP2 PRKD2 CTTNBP2 PODXL PPP1R12B SKIDA1 LAMC3 SLC25A26 TFAP4 ARHGAP1 BMP6 TOX3 ROBO1 QSER1 TANGO6 PLCE1 | 4.83e-04 | 1345 | 136 | 16 | EFO_0010736 |
| Disease | ascending aortic diameter | 4.90e-04 | 140 | 136 | 5 | EFO_0021787 | |
| Disease | protein sel-1 homolog 2 measurement | 5.80e-04 | 8 | 136 | 2 | EFO_0801962 | |
| Disease | programmed cell death 1 ligand 2 measurement | 5.80e-04 | 8 | 136 | 2 | EFO_0008268 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 5.80e-04 | 8 | 136 | 2 | EFO_0801768 | |
| Disease | asparaginase-induced acute pancreatitis | 7.43e-04 | 9 | 136 | 2 | EFO_1001507 | |
| Disease | Schizophrenia | CACNA1C PDE4B TSNARE1 GRB2 RB1CC1 ITGAM CLOCK PDLIM5 ARHGAP1 PRODH2 BRCA1 BTG1 | 8.18e-04 | 883 | 136 | 12 | C0036341 |
| Disease | Fanconi anemia (is_implicated_in) | 9.26e-04 | 10 | 136 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | S-warfarin to R-warfarin ratio measurement | 9.94e-04 | 95 | 136 | 4 | EFO_0803331 | |
| Disease | serum gamma-glutamyl transferase measurement | NUP210L SIPA1L3 PGAP6 RYR2 PARD6B RCOR1 EYS CELSR2 PTPRM ROBO1 AKAP13 PLCE1 | 1.10e-03 | 914 | 136 | 12 | EFO_0004532 |
| Disease | late onset Parkinson's disease (is_implicated_in) | 1.13e-03 | 11 | 136 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | Tachycardia, Ventricular | 1.13e-03 | 11 | 136 | 2 | C0042514 | |
| Disease | schizophrenia, gastroesophageal reflux disease | 1.13e-03 | 11 | 136 | 2 | EFO_0003948, MONDO_0005090 | |
| Disease | Cognitive impairment | 1.13e-03 | 11 | 136 | 2 | HP_0100543 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 1.18e-03 | 45 | 136 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | myocardial infarction | 1.23e-03 | 350 | 136 | 7 | EFO_0000612 | |
| Disease | phosphatidylethanolamine measurement | 1.27e-03 | 173 | 136 | 5 | EFO_0010228 | |
| Disease | Myocardial Ischemia | 1.37e-03 | 176 | 136 | 5 | C0151744 | |
| Disease | schizophrenia, anorexia nervosa | 1.42e-03 | 48 | 136 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | amygdala volume | 1.59e-03 | 13 | 136 | 2 | EFO_0006934 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 1.59e-03 | 13 | 136 | 2 | cv:C4082197 | |
| Disease | revision of total hip arthroplasty | 1.85e-03 | 14 | 136 | 2 | EFO_0020973 | |
| Disease | cortical thickness | FNIP2 CTTNBP2 NUP210L LAMC3 SLC25A26 CLOCK TFAP4 BMP6 DLC1 TOX3 ROBO1 QSER1 PLCE1 | 1.95e-03 | 1113 | 136 | 13 | EFO_0004840 |
| Disease | cleft lip | 2.09e-03 | 284 | 136 | 6 | EFO_0003959 | |
| Disease | ovarian cancer (is_implicated_in) | 2.22e-03 | 56 | 136 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | mean arterial pressure | 2.26e-03 | 499 | 136 | 8 | EFO_0006340 | |
| Disease | Hypertrophic Cardiomyopathy | 2.34e-03 | 57 | 136 | 3 | C0007194 | |
| Disease | hypertension (is_implicated_in) | 2.42e-03 | 121 | 136 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | focal segmental glomerulosclerosis | 2.43e-03 | 16 | 136 | 2 | EFO_0004236 | |
| Disease | Pre-Eclampsia | 2.43e-03 | 16 | 136 | 2 | C0032914 | |
| Disease | urate measurement, spine bone mineral density | 2.46e-03 | 58 | 136 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | platelet component distribution width | CACNA1C SH3TC2 NUP210L CLDN4 DLC1 PTPRH GCC2 MOV10L1 AKAP13 NOS3 | 2.68e-03 | 755 | 136 | 10 | EFO_0007984 |
| Disease | polycystic ovary syndrome | 2.71e-03 | 60 | 136 | 3 | EFO_0000660 | |
| Disease | pre-eclampsia (biomarker_via_orthology) | 2.74e-03 | 17 | 136 | 2 | DOID:10591 (biomarker_via_orthology) | |
| Disease | Malignant Neoplasms | 2.96e-03 | 128 | 136 | 4 | C0006826 | |
| Disease | systolic blood pressure, alcohol drinking | 2.96e-03 | 128 | 136 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | hypertension | 3.07e-03 | 307 | 136 | 6 | EFO_0000537 | |
| Disease | Disorder of eye | 3.07e-03 | 212 | 136 | 5 | C0015397 | |
| Disease | Tinnitus | 3.13e-03 | 130 | 136 | 4 | HP_0000360 | |
| Disease | Calcium channel blocker use measurement | 3.13e-03 | 213 | 136 | 5 | EFO_0009930 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 3.25e-03 | 64 | 136 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | blood metabolite measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0005664 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.70e-03 | 67 | 136 | 3 | C3463824 | |
| Disease | Benign Neoplasm | 3.86e-03 | 68 | 136 | 3 | C0086692 | |
| Disease | Neoplasms | 3.86e-03 | 68 | 136 | 3 | C0027651 | |
| Disease | BREAST CANCER | 4.18e-03 | 21 | 136 | 2 | 114480 | |
| Disease | bipolar I disorder | 4.19e-03 | 141 | 136 | 4 | EFO_0009963 | |
| Disease | mitochondrial DNA measurement | 4.24e-03 | 328 | 136 | 6 | EFO_0006312 | |
| Disease | Manic Disorder | 4.35e-03 | 71 | 136 | 3 | C0024713 | |
| Disease | progranulin measurement | 4.59e-03 | 22 | 136 | 2 | EFO_0004625 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARNTVTQVLSRFTSQ | 501 | Q9P2B4 | |
| VNTITSTLQDTSRNL | 41 | Q6ZU80 | |
| FNTTTNVVILAGTNR | 441 | Q9Y4W6 | |
| VTFAVLSSVSTIRNQ | 586 | Q6QNK2 | |
| INASTLVRNSTQFLA | 11 | Q49SQ1 | |
| ISSSVANLTVRNLTR | 536 | Q8IZP9 | |
| ANLTVRNLTRNVTVT | 541 | Q8IZP9 | |
| ANRRSQQSVSLSKSV | 1891 | Q12802 | |
| QTLDTSQTRFNVRTE | 166 | Q8TCU4 | |
| QINSTRILSSQNFTL | 156 | Q8IV13 | |
| SVITYQITSGNTRNR | 641 | Q9HCU4 | |
| QITSGNTRNRFSITS | 646 | Q9HCU4 | |
| SATRVVGQIFNTSRN | 181 | Q96K78 | |
| STQFRINARSGEITT | 716 | Q9H251 | |
| VSQALIRSFSSTARN | 6 | P24310 | |
| NVRTVFSNVFNNTTA | 21 | Q9UF12 | |
| TVVTSRVVNRANTVQ | 51 | Q14624 | |
| ISNAENSVSQLISRS | 496 | Q9HBD1 | |
| AVSANATAATTVLRQ | 326 | Q9UKL0 | |
| FNVTSTLRINTTTNE | 191 | Q9NZQ7 | |
| LSNSSVVNFQETTRQ | 216 | Q2KHR3 | |
| NNRNQEFVSSSRSIS | 1001 | Q2KHR3 | |
| FRNRSISLSQSAENV | 1011 | Q4ADV7 | |
| LQVFLRTTLRQSATS | 261 | Q14573 | |
| ATNTVIVTNSENARS | 606 | Q2M385 | |
| QRNNVVRNSRTSGSS | 251 | Q9BYG5 | |
| LAERSQRSQIANITT | 666 | Q86VD1 | |
| SNQTIFASTLRSIVQ | 346 | A5PLL1 | |
| ISQRSQTEAVTFLAN | 146 | Q9Y2S7 | |
| RTSLIAEQQTNFNTV | 1321 | Q8TDY2 | |
| VTQRTAFQIRQFQRS | 951 | Q9NVI1 | |
| ITASSVISQRTQQTS | 266 | O00592 | |
| EQQRKFSSQSSRALT | 386 | Q5HY92 | |
| TAVSNVNVLSRIQNS | 741 | A0AUZ9 | |
| VNVLSRIQNSSRNTA | 746 | A0AUZ9 | |
| IQISSFTQADLTSRN | 2256 | Q86XX4 | |
| TTVVVTAQKRNSRRQ | 476 | Q9BXT6 | |
| RNLQFTTISLNFSTT | 2996 | Q5T1H1 | |
| IANSQIAASSVRVTF | 81 | Q08431 | |
| IIASFSITSVQRSDN | 156 | Q12866 | |
| TTVFNSAQRLEVVRN | 541 | Q86WG5 | |
| LQITSIANATTRQDR | 151 | Q16836 | |
| SRVTISVDRSKNQFS | 86 | A0A087WSY4 | |
| SVTQNRLEVNISQST | 876 | O43451 | |
| SSKTRQIISTIRTQN | 356 | P37268 | |
| RFVQTNISRLLQETS | 121 | P49771 | |
| ATVTRSQSLNIRTTQ | 331 | O00443 | |
| QVLASLRSVRNNFTI | 171 | Q07343 | |
| LLQAAASTTRAQTTR | 16 | P22079 | |
| TFQSSSRNRTQLKVL | 266 | Q86UK5 | |
| RQASLSISVSNSQIQ | 526 | Q9BZL6 | |
| RVEVSRRIFQTQTSS | 291 | Q8N7C0 | |
| QQVRSPVTNIARTSF | 41 | Q96CW1 | |
| NSSPSVRSNIRVTVT | 551 | Q5XXA6 | |
| STAQTVAQQRAATLL | 536 | Q9HCN3 | |
| GTTQSRSFRILAQIT | 276 | Q96HC4 | |
| QAISAIQALRSSVSR | 16 | Q6P2C8 | |
| TSFRNITQLSFQLIS | 161 | Q6IE36 | |
| RSTSVSRNQQIFLRD | 136 | P62993 | |
| LRQQSAQSQVSTTAE | 431 | Q9H0A0 | |
| YTRQTAALQQVLSTR | 511 | Q9Y2X0 | |
| TQEVTSRIRTQSFSL | 1166 | P29474 | |
| QRVTSTQQQTRISAS | 246 | P49023 | |
| TQQQTRISASSATRE | 251 | P49023 | |
| STVSTISRNNIRENV | 1021 | P38398 | |
| SQLRASRVQSGTRQS | 91 | Q569G3 | |
| LQNTITSGIVSSAQR | 266 | O43464 | |
| LQLNRTATTFSTLQI | 436 | Q6WRI0 | |
| TQRSQTQTILANADT | 1596 | Q9Y2F5 | |
| INATASETFTVLQQR | 21 | Q8NCX0 | |
| ATISTVSSTQRKRQQ | 71 | Q13936 | |
| EQRVRFLSNASTLAS | 411 | O43497 | |
| QLARNTVTQALSRFT | 486 | Q8WZ74 | |
| RSQSISTQNVRNFGR | 931 | Q9P278 | |
| LANTSVRFQNSQISS | 1071 | Q9HC77 | |
| TQTVSQLTSQNEVLR | 1426 | Q8IWJ2 | |
| NRSTQSQDVARVSSA | 386 | P22004 | |
| TQVSRANFELTSVTQ | 551 | Q8NEU8 | |
| SQFRNQTESSNVSRI | 241 | Q9Y5Q5 | |
| ATSTLNRFSALQQAV | 1116 | Q04637 | |
| QRSQLQIFSSVLQTS | 21 | Q9HBG7 | |
| ESFRTINSSNSVTNR | 856 | Q8TEP8 | |
| SQIQSSAQRLETQVS | 861 | Q13751 | |
| SAQRLETQVSASRSQ | 866 | Q13751 | |
| ITQGRANSTITQLTA | 1581 | A4D0S4 | |
| VVKQRAQVSASTRTF | 111 | Q70HW3 | |
| AQVSASTRTFQIFSN | 116 | Q70HW3 | |
| YNRTRRISQTSQVSV | 2801 | Q92736 | |
| VLITTRTAADNFSTQ | 106 | P54277 | |
| VSRVSSVLNRNTRQF | 11 | Q86WQ0 | |
| FSISNQTVAVVNRRG | 1116 | Q5VU65 | |
| LSQSTRTATFQQRFD | 41 | Q9BY77 | |
| TSSRRFIASFNVVNT | 236 | P28827 | |
| RTLQQEAVARQTTFL | 731 | Q9H0X9 | |
| RGLFRSLQQAQSVTS | 1306 | Q5T011 | |
| ARSVTRTIQNNFFDS | 456 | O43426 | |
| TVNSIFQVIRSCNRS | 766 | Q9P212 | |
| NVTRGAVQNTIERFT | 251 | Q6ZSG1 | |
| RLIQSITGTSVSQNV | 136 | Q15544 | |
| TRANVFVQLRGTVST | 1246 | Q9NTG1 | |
| ISVRLQRATTSQATQ | 601 | Q8IV61 | |
| TVTNTFRTNNIQIQS | 666 | Q5UE93 | |
| TTEGIFRRSANTQVV | 276 | Q07960 | |
| TQLTISIQNTRNRFE | 226 | Q9UNA1 | |
| SSQVSVQSIRFRRTS | 456 | Q1XH10 | |
| ASQQFLSSVIQNLRT | 256 | Q99460 | |
| VSQVLNRLTFASTLS | 466 | P30876 | |
| AANRVSVSQRRNTTT | 356 | O60292 | |
| FATIRTASLVSRQIQ | 466 | Q9UL54 | |
| TQALAQRTQQDSTRT | 76 | Q8WW24 | |
| SARLVSIQSQRAQFL | 96 | Q8TF17 | |
| DLRTSTSQAVFRLQS | 186 | P14868 | |
| FNETKNSTRRQTQVL | 691 | P11215 | |
| NSTRRQTQVLGLTQT | 696 | P11215 | |
| ADTISVNQTRVNLSS | 401 | Q96QB1 | |
| LTSERQLQTFSQSLQ | 31 | P62324 | |
| RVTAFIGSNIVTSQT | 31 | O14493 | |
| AVTTFTQDRQIRFSQ | 691 | O15516 | |
| SSNLFQIRTTATQEN | 201 | Q9BXN2 | |
| ANVFRINSSVTSLER | 266 | Q96NA8 | |
| ITTSAFNKERTRQAT | 141 | Q8IVN8 | |
| NNVNVSSRVQSTAFF | 181 | Q5TBB1 | |
| STSAVASRSQRQKNL | 76 | Q13905 | |
| VFNRLTVSQGNTSVQ | 1286 | Q7Z4S6 | |
| QAARIIRNTTALFSQ | 406 | Q15413 | |
| DIFSRISQQVEQSRS | 46 | Q6VEQ5 | |
| AASVTAKSSVQRRSQ | 516 | Q92610 | |
| DIFSRISQQVEQSRS | 46 | A8K0Z3 | |
| LSSNATTSLVQRRKQ | 36 | A6XGL0 | |
| VATSTLRSISNNRSV | 541 | Q5GH76 | |
| RQFQRVATTTFITLS | 391 | Q9C0B7 | |
| DIFSRISQQVEQSRS | 46 | C4AMC7 | |
| SVSQTGDLTITNVQR | 406 | Q9Y6N7 | |
| RAASASQQLSVITVQ | 661 | Q96NL6 | |
| EAQTIRSVQQTLAST | 336 | O15405 | |
| TDIQTAVRTNSTFVQ | 206 | P07602 | |
| FVETQASQGTLQTRT | 2606 | P78527 | |
| TLSTRSTANQSFRKV | 1331 | Q13464 | |
| SDLTRSQNSIRNSSQ | 131 | Q9UK13 | |
| RNKTSVTRQADFVQT | 586 | Q14694 | |
| SSTQLRIVVSSFLRQ | 1561 | A6NGW2 | |
| AIEQVRFRISNSSTA | 706 | Q12789 | |
| DRTNSVNTAFTALRT | 86 | Q7RTU7 | |
| VRNLRVEAQTTSSIS | 211 | Q9HD43 | |
| SVSTSRQNLDTIVQA | 261 | Q01664 | |
| DTTRQVQRISCFQST | 121 | Q9HAD4 | |
| RTLQTAAQATLRQTE | 1291 | Q9Y6N6 | |
| ASRLTSQTQATLQQA | 1426 | Q9Y6N6 | |
| SFRQSRSNLTSLLVQ | 366 | Q58DX5 | |
| SRQSTASRQSVVSKQ | 211 | P52179 | |
| AQVQAFRDTQTSVSL | 606 | Q5VTT5 | |
| QSRRSTQGVTLTDLQ | 691 | O14974 | |
| QTRRSTQGVTLTDLQ | 641 | O60237 |